Inventor · disambiguated record
Hermann Russ
Also filed as: BARTOSZYK GERD · RUSS HERMANN · RUSS HERMANN KURT
7 granted patents·9 pending applications·4 citations·filing 2001–2024
74Inventor score
Files withGALIMEDIX THERAPEUTICS INC3MERCK PATENT GMBH2MERZ PHARMA GMBH & CO KGAA2Prilenia Neurotherapeutics Ltd2TEVA PHARMACEUTICALS INT GMBH2
Top patents by PatentIndex Score
16 records- 0174US11738012B2Treatment of neurodegenerative eye disease using pridopidinePrilenia Neurotherapeutics Ltd·Filed 2017·Granted Aug 29, 2023·1 cites·42 claims
- 0271US10987400B2Methods for the treatment of glaucoma and age-related macular degeneration by a peptide D-TRP-AIBUNIV RAMOT·Filed 2019·Granted Apr 27, 2021·0 cites·10 claims
- 0371US9717772B2Interval therapy for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseasesRAMOT AT TEL-AVIV UNIV LTD·Filed 2013·Granted Aug 1, 2017·2 cites·15 claims
- 0470US10525097B2Methods for the treatment of glaucoma and age-related macular degeneratiion by a peptide D-TRP-AIBUNIV RAMOT·Filed 2016·Granted Jan 7, 2020·1 cites·6 claims
- 0570US2024238393A1Composition comprising botulinum toxinMERZ PHARMA GMBH & CO KGAA·Filed 2024·Application pending·0 cites
- 0661US11969461B2Composition comprising botulinum toxinMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted Apr 30, 2024·0 cites·13 claims
- 0756US2011288105A1Eltoprazine for the treatment of l-dopa-induced dyskinesiaVALASTRO BARBARA·Filed 2009·Application pending·0 cites
- 0853US2022062255A1Treatment of neurodegenerative eye disease using pridopidinePrilenia Neurotherapeutics Ltd·Filed 2021·Application pending·0 cites
- 0951US2025275944A1Relative undersupply of an amyloid beta aggregation inhibitor for improved detoxifying effectsGALIMEDIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1046US7928128B2Use of(R)-(−) -2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable saltsMERCK PATENT GMBH·Filed 2001·Granted Apr 19, 2011·0 cites·7 claims
- 1145US2023242483A1Crystalline forms of solvates of tryptophan derivatives, compositions comprising them and uses thereofGALIMEDIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1245US2020121812A1Combination of Deuterated Levodopa With Carbidopa and Opicapone For The Treatment of Parkinson's DiseaseTEVA PHARMACEUTICALS INT GMBH·Filed 2019·Application pending·0 cites
- 1341US7618988B2Use of substituted aminomethyl chromansMERCK PATENT GMBH·Filed 2002·Granted Nov 17, 2009·0 cites·20 claims
- 1441US2004235920A1Novel use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disordersFiled 2002·Application pending·0 cites
- 1541US2022193035A1Indole compounds for use in neurorestorationGALIMEDIX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1638US2017165381A1Combination of Deuterated Levodopa With Carbidopa and Opicapone For The Treatment of Parkinson's DiseaseTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hermann Russ files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →